Atlas Trials

A Study to Evaluate the Impact of Escitalopram on Quality of Life and Social Functionality in Patients With Major Depressive Disorder With Anxiety Symptom

Clinical trial NCT01870843 · COMPLETED

Trial details

NCT number
NCT01870843
Sponsor
Xian-Janssen Pharmaceutical Ltd.
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Depressive Disorder, Major
Start date
2014-03-01
Primary completion
2015-05-01
Enrollment
261

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.